FDA Inspection
Rafaelito S. Victoria, MDRafaelito S. Victoria, MD – FDA Inspection, Sep 25, 2020
Record Details
This FDA Inspection record concerns Rafaelito S. Victoria, MD, with an inspection on September 25, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Rafaelito S. Victoria, MD
- Inspection Date
- September 25, 2020
- Product Type
- Drugs
View Company Profile
ID · dde28a65-b859-4ebd-a59c-d2107580398a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1130001
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
6- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.64(b)Safety reports
- 21 CFR 312.64(d)Financial info
- 21 CFR 50.20Circumstances of obtaining consent
- 21 CFR 50.25(a)(7)Whom to contact
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rafaelito S. Victoria, MD
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2022 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 19, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 30, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Rafaelito S. Victoria, MD
- FDA Inspection 1171586 - 2022-06-10
- FDA Inspection 1015303 - 2017-05-19
- FDA Inspection 863573 - 2014-01-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.